Selected commentary, bylines and coverage.
Curated, not exhaustive. Grouped by the work they evidence.
Building partner programmes that compound revenue.
Sapio Sciences and Zifo Announce Strategic Partnership
Coverage of the Sapio and Zifo strategic partnership, with CEO Raj Prakash describing how the integration of LDAS with the Sapio Platform unlocked AI adoption in biotech and pharma labs.
Read on Cambridge Network →EPAM Joins Sapio Sciences Partner Program
Tier-one services partner EPAM joins the Sapio partner programme, expanding global delivery capability across life sciences and healthcare informatics.
Read on Cambridge Network →Sapio Sciences Launches Partner Program
Tier-one life sciences trade coverage of the Sapio partner programme launch, designed to accelerate research and diagnostics through deployment, consulting and technology partners.
Read in The Scientist →Why ecosystems beat tools, and where AI risk lives.
From AI Tools to AI Ecosystems: Why Lab Sciences Companies Are Rethinking
Why isolated AI tools underperform AI ecosystems, and what this shift means for lab science companies architecting their next generation of platform partnerships.
Read on IPT Online →AI Hallucinations Are Eroding Trust in Lab Tools
The trust problem with generative AI in regulated lab environments, and the architectural choices that separate credible AI from confident-sounding noise.
Read on Bioscience Today →CCDC AI Technology Partnership with Sapio Sciences
The Cambridge Crystallographic Data Centre announces an AI technology partnership with Sapio Sciences, evidencing the ecosystem thesis with a credible scientific institution.
Read on CCDC →Operating credibility for the boards of healthtech and life sciences SaaS.
How LIMS Is Redefining Data Management in Modern Research and Clinical Labs
Long-form interview on the role of modern lab informatics in research and clinical efficiency, and where boards should be paying attention to the data layer.
Read in BioPharma Boardroom →Accelerating Diagnosis and Drug Development with Better-Managed Datasets
How disciplined data management changes the economics of diagnosis and drug development, with implications for SaaS platforms supporting biopharma R&D.
Read in Pharmaceutical Technology →Track record across four prior exits.
Apertio Aims for 2007 IPO
Pre-exit coverage of Apertio, the network platform business subsequently acquired by Nokia. One of four prior exits in Andrew's operating history.
Read on Light Reading →Lumeon Portfolio Page
Investor portfolio reference for Lumeon, the deterministic clinical-pathway orchestration platform where Andrew served in the executive team during its venture-backed scale phase.
Read on Amadeus Capital →Frameworks for the lab as it absorbs AI.
From Digital Filing Cabinets to Co-Scientists: Three Stages of Lab AI Maturity
A maturity framework for lab AI, from passive data systems through assistive tools to AI as a co-scientist, with implications for platform architecture and partner strategy.
Read on Technology Networks →The ELN's New Role in Modern AI-Enabled Labs
How the electronic lab notebook category is being redefined by AI, and what changes for platform vendors, services partners and the labs themselves.
Read in Lab Manager →Tier-one publications, broader coverage.
Enterprise social-media risk and corporate data protection
Commentary during Andrew's Clearswift tenure on the risks enterprises were facing as social media moved into corporate workflows.
Read in WSJ →Enterprise social-media policy and data-protection trends
FT coverage of how organisations were responding to social-media risk and data-protection demands, with input from Andrew at Clearswift.
Read in the FT →Early smartphone adoption and usability
Comment on the friction of early smartphone adoption — context from Andrew's mobile telecoms operating period before Apertio.
Read on BBC News →Big data, big challenge: how life sciences turn information overload into insight
Andrew byline on the data-management discipline that lets life sciences platforms convert volume into actual decisions, and where the platform layer matters.
Read on TechRadar Pro →Sapio Sciences Partner Program Welcomes Astrix
Tier-one bioinformatics trade coverage of Astrix joining the Sapio partner programme during Andrew's CGO tenure, expanding services capability across the platform.
Read in Bio-IT World →A curated selection across six bodies of work. Older press from prior exits and earlier roles is not listed but available on request. For interview, comment or quote requests, use the contact form below.
Clarity when it counts.
For interview, comment or quote requests, or to discuss a board, advisory or fractional engagement, email directly. Thirty minutes is usually enough to test fit.
Book a 30-minute intro call